Find therapies in clinical trials near you – page 14

Phase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis

A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis